Peng et al. studied the lncRNA Airn in genetically engineered mice with intramyocardial AAV injection, showing that Airn suppresses myocardial fibrosis in diabetic cardiomyopathy via the IMP2/p53 axis in an m6A-dependent manner [100]. Here, AIRN is linked to diabetic cardiomyopathy.